Authors:
Trope, C
Kaern, J
Hogberg, T
Abeler, V
Hagen, B
Kristensen, G
Onsrud, M
Pettersen, E
Rosenberg, P
Sandvei, R
Sundfor, K
Vegote, I
Citation: C. Trope et al., Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument, INT J GYN C, 11, 2001, pp. 20-20
Authors:
Trope, C
Kaern, J
Hogberg, T
Abeler, V
Hagen, B
Kristensen, G
Onsrud, M
Pettersen, E
Rosenberg, P
Sandvei, R
Sundfor, K
Vergote, I
Citation: C. Trope et al., Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument, ANN ONCOL, 11(3), 2000, pp. 281-288
Authors:
Dorum, A
Heimdal, K
Lovslett, K
Kristensen, G
Hansen, LJ
Sandvei, R
Schiefloe, A
Hagen, B
Himmelmann, A
Jerve, F
Shetelig, K
Fjaerestad, I
Trope, C
Moller, P
Citation: A. Dorum et al., Prospectively detected cancer in familial breast/ovarian cancer screening, ACT OBST SC, 78(10), 1999, pp. 906-911
Authors:
Trope, C
Hogberg, T
Kaern, J
Bertelsen, K
Bjorkholm, E
Boman, K
Himmelmann, A
Horvath, G
Jacobsen, A
Kuoppola, T
Vartianen, J
Lund, B
Onsrud, M
Puistola, U
Salmi, T
Scheistroen, M
Sandvei, R
Simonsen, E
Sorbe, B
Tholander, B
Westberg, R
Citation: C. Trope et al., Long-term results from a phase II study of single agent paclitaxel (Taxol (R)) in previously platinum treated patients with advanced ovarian cancer: The Nordic experience, ANN ONCOL, 9(12), 1998, pp. 1301-1307